These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29507558)

  • 1. Quality of life in asthmatic children and their caregivers after two-year treatment with omalizumab, a real-life study.
    Sztafińska A; Jerzyńska J; Stelmach W; Woicka-Kolejwa K; Stelmach I
    Postepy Dermatol Alergol; 2017 Oct; 34(5):439-447. PubMed ID: 29507558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of budesonide inhalation suspension compared with cromolyn sodium nebulizer solution on health status and caregiver quality of life in childhood asthma.
    Murphy KR; Fitzpatrick S; Cruz-Rivera M; Miller CJ; Parasuraman B
    Pediatrics; 2003 Sep; 112(3 Pt 1):e212-9. PubMed ID: 12949315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omalizumab improves asthma-related quality of life in children with allergic asthma.
    Lemanske RF; Nayak A; McAlary M; Everhard F; Fowler-Taylor A; Gupta N
    Pediatrics; 2002 Nov; 110(5):e55. PubMed ID: 12415061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric asthma caregiver's quality of life questionnaire is a useful tool for monitoring asthma in children.
    Stelmach I; Podlecka D; Smejda K; Majak P; Jerzyńska J; Stelmach R; Janas A; Stelmach W
    Qual Life Res; 2012 Nov; 21(9):1639-42. PubMed ID: 22138965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study.
    Niven R; Chung KF; Panahloo Z; Blogg M; Ayre G
    Respir Med; 2008 Oct; 102(10):1371-8. PubMed ID: 18657960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of Life of asthmatic children and their caregivers.
    Ibrahim NK; Alhainiah M; Khayat M; Abulaban O; Almaghrabi S; Felmban O
    Pak J Med Sci; 2019; 35(2):521-526. PubMed ID: 31086544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of quality of life in Iranian asthmatic children, young adults and their caregivers.
    Zandieh F; Moin M; Movahedi M
    Iran J Allergy Asthma Immunol; 2006 Jun; 5(2):79-83. PubMed ID: 17237581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Prospective Study to Assess the Quality of Life in Children with Newly Diagnosed Asthma and Their Caregivers using the Pediatric Asthma Quality of Life Questionnaire.
    Battula M; Arunashekar P; Nagarajan VP
    J Prim Care Community Health; 2020; 11():2150132720961272. PubMed ID: 33016181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of omalizumab in children and adolescents with uncontrolled allergic asthma: a case series from Poland.
    Sztafińska A; Gwardys M; Podlecka D; Mospinek E; Stelmach I
    Postepy Dermatol Alergol; 2021 Jun; 38(3):427-432. PubMed ID: 34377123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term omalizumab treatment in severe allergic asthma: the South-Eastern Mediterranean "real-life" experience.
    Tzortzaki EG; Georgiou A; Kampas D; Lemessios M; Markatos M; Adamidi T; Samara K; Skoula G; Damianaki A; Schiza S; Tzanakis N; Siafakas NM
    Pulm Pharmacol Ther; 2012 Feb; 25(1):77-82. PubMed ID: 22155001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic efficacy of omalizumab in children with moderate-to-severe allergic asthma combined with chronic sinusitis.
    Chong W; Li H; Wang J
    Front Allergy; 2023; 4():1236798. PubMed ID: 37908372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omalizumab: a review of its use in the management of allergic asthma.
    Bang LM; Plosker GL
    Treat Respir Med; 2004; 3(3):183-99. PubMed ID: 15219177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spotlight on omalizumab in allergic asthma.
    Bang LM; Plosker GL
    BioDrugs; 2004; 18(6):415-8. PubMed ID: 15571425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of omalizumab as add-on therapy on asthma-related quality of life in severe allergic asthma: a Brazilian study (QUALITX).
    Rubin AS; Souza-Machado A; Andradre-Lima M; Ferreira F; Honda A; Matozo TM;
    J Asthma; 2012 Apr; 49(3):288-93. PubMed ID: 22356355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of omalizumab as add-on therapy to Quality of Life Questionnaire for Korean Asthmatics (KAQLQ) in Korean patients with severe persistent allergic asthma.
    Jung JW; Park HS; Park CS; Cho SH; Choi IS; Moon HB; Kwon SS; Yoon HJ; Park JW; Lee JM; Choi DC; Choi BW
    Korean J Intern Med; 2021 Jul; 36(4):1001-1013. PubMed ID: 34237826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
    Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K
    Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exhaled nitric oxide in children with asthma receiving Xolair (omalizumab), a monoclonal anti-immunoglobulin E antibody.
    Silkoff PE; Romero FA; Gupta N; Townley RG; Milgrom H
    Pediatrics; 2004 Apr; 113(4):e308-12. PubMed ID: 15060258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved quality-of-life of caregivers of children with asthma through guideline-based management.
    Sheikh SI; Pitts J; Ryan-Wenger NA; Kotha K; McCoy KS; Stukus DR
    J Asthma; 2017 Sep; 54(7):768-776. PubMed ID: 27831828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quality of life in patients with allergic asthma on treatment with omalizumab].
    Aguilar-Hinojosa NK; Sánchez-Tec G
    Rev Alerg Mex; 2018; 65(4):349-356. PubMed ID: 30602204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Experience with Anti-IgE Monoclonal Antibody (Omalizumab) in Pediatric Severe Allergic Asthma-A Romanian Perspective.
    Berghea EC; Balgradean M; Pavelescu C; Cirstoveanu CG; Toma CL; Ionescu MD; Bumbacea RS
    Children (Basel); 2021 Dec; 8(12):. PubMed ID: 34943337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.